;46(2) 17] Key words: Bisphosphonate, hypercalcemia of malignancy, rehydration Hiperkalsemia pada Keganasan: Karakteristik Klinik dan Luaran. ;46(2)–17] Key words: Bisphosphonate, hypercalcemia of malignancy, rehydration Hiperkalsemia pada Keganasan: Karakteristik Klinik dan Luaran. ;46(2)–17]. Key words: Bisphosphonate, hypercalcemia of malignancy, rehydration. Hiperkalsemia pada Keganasan: Karakteristik.
|Published (Last):||14 December 2017|
|PDF File Size:||19.76 Mb|
|ePub File Size:||14.58 Mb|
|Price:||Free* [*Free Regsitration Required]|
Hasan Sadikin General Hospital Abstract Hypercalcemia is one of the most common paraneoplastic syndromes in hospitalized malignancy patients. The difference in the changes of ion calcium mechanisms that are thought to be important between subjects treated with biophosphonate during the development of hypercalcemia include and those who did not receive bisphosphonate bone-resorbing cytokines; parathyroid hormone- was calculated by Mann—Whitney test.
Gejala klinis yang ditemukan adalah gangguan kesadaran pada 4 subjek, dehidrasi pada 18 subjek, konstipasi pada 6 subjek, mual dan muntah pada 6 subjek. The difference of decreasing ion calcium level between subjects who received bisphosphonate and nor was 0. Jpn J Clin Oncol.
Dari 40 penderita dengan hiperkalsemia pada keganasan, didapatkan 22 keganasan hematologi dan 18 tumor padat. Intracellular Fluid ICF 2. Neoplasma can alter calcium homeostasis indirectly through the production of endocrine factors resulting in humoral hypercalcemia of malignancy.
The difference between ion calcium level before and after treatment was calculated by Wilcoxon test. The kidneys make urine as well as determining how concentrate or dilute the urine. The management of patients with HCM The changes in ion calcium level before and depends on the severity of symptoms and the after treatment were available in 29 subjects degree of hypercalcemia. The kidneys make ihperkalsemia as well as determining how concentrate or dilute the urine More information.
Hiperkaldemia bisphosphonate before and after treatment were Control.
These agents may exacerbate fluid loss; therefore, their use should be limited to the volume repleted patient and only then with close monitoring of volume status. J Am Soc and zoledronate. The rapidity of onset is more likely to correlate with the symptom severity rather than the degree of hypercalcemia. The difference in the decreasing ion hypercalcemia is usually successful, the presence calcium level between the group who received of this complication is associated with a poor bisphosphonate and not was 0.
The aim of this study was to determine the clinical characteristics and treatment outcome in hypercalcemia of malignancy.
Medical therapy is, two principles, i. Overview Review Series Immunodiagnostic Systems Limited 1 Background Disorders of mineral and bone metabolism are common in chronic hiperalsemia disease. Pharmacotherapy in the Elderly.
Hiperkalsemia pada Keganasan: Karakteristik Klinik dan Luaran Terapi
The process of metabolism transforms lipophilic drugs into more polar, hydrophilic, readily More information. How do loop diuretics cause hypokalemia? Treatment either with bisphosphonate or normal saline rehydration alone gave good result. There were 40 patients with hypercalcemia of malignancy, consisted of 22 hematologic malignancies and 18 solid tumors.
All subjects received rehydration with normal saline. Disturbance of consiousness were found in 4, dehydration in 18, constipation in 6, and nausea and vomiting in 6 subjects. Bisphosphonate was given in 26 subjects. Pharmacology Axalah Nursing Pharmacology Principles 1.
There were 40 patients with hypercalcemia of malignancy, consisted of hiperkalsemoa hematologic malignancies and 18 solid tumors. This was a study using medical records of patients with malignancy hospitalized in the Departement of Internal Medicine, Dr. In order for these More information.
Hiperka,semia focal osteolysis in metastasis eligible for this study. Help Center Find new research papers in: The approach and organization of this material was developed by Bowman O.
Among that include pamidronate, alendronate, and hematologic malignancy, malignant lymphoma ibandronate, inhibit protein prenylation which followed by myeloma multiple. Among solid tumor, the most frequent one was breast cancer followed by lung cancer and head and neck cancer.
WikiPage – eAnswers
The CAS registry number More information. Adalha Necessity Criteria Subject: A practical approach In continental Europe, the United Kingdom to hypercalcemia. Fluids Water Fluids and Electrolytes.